Your ISB Site Isn’t Failing. It’s Just Cold.
There are thousands of in situ bioremediation sites across the country where the remedy is working — technically. The bugs are there. The amendments are going in. Concentrations are declining. Just not fast enough, and not to closure.
That gap applies at two very different points in a site's life. For sites already running ISB that are taking too long — five years in, concentrations declining but closure nowhere in sight — temperature is most often the missing variable. But the more important conversation happens earlier: during RI/FS and remedial technology screening, when the question isn't "why isn't this working?" but "what should we design?" If bioremediation is applicable for your site but passive ISB timelines are too long or too uncertain to satisfy regulators, stakeholders, or project economics, low-temperature heat-enhanced bioremediation and recirculation deserves serious consideration from the start — not as a corrective measure, but as the designed remedy.
The Biology Is Temperature-Dependent. Always Has Been.
This is true whether you are remediating chlorinated volatile organic compounds (CVOCs) or petroleum hydrocarbons. Reductive dechlorination — the microbial pathway that degrades TCE, PCE, and their daughter products — is governed by what microbiologists call the Q₁₀ relationship: metabolic rates roughly double with every 10°C rise through the biological optimum window. The same thermal sensitivity applies to the aerobic and anaerobic degradation pathways responsible for breaking down BTEX compounds and TPH fractions.
Most contaminated aquifers in the continental United States sit at 10–15°C. Dehalococcoides and related dechlorinating organisms perform best at 30–35°C. Hydrocarbon-degrading consortia — the Pseudomonas, Rhodococcus, and sulfate-reducing communities that process benzene, toluene, and heavier TPH fractions — are similarly constrained by low ambient temperatures. In both cases, the gap between groundwater temperature and the biological optimum is the single largest untapped performance lever available — whether you are designing a new remedy or troubleshooting one that has stalled.
The practical consequence is straightforward: an amendment program that looks well-designed on paper — good electron donor loading, appropriate pH buffering, documented microbial community — can still underperform if the subsurface is simply too cold for the organisms to operate at their potential. And a technology screening that evaluates passive ISB without evaluating thermally enhanced ISB is leaving a meaningful performance option off the table.
This Isn't Theory. It's Physics and Field Data.
The relationship between temperature and biodegradation rate is well-established in the peer-reviewed literature, and it has been confirmed repeatedly in the field. Across dozens of projects worldwide — CVOC sites, petroleum release sites, mixed-plume sites — modest thermal enhancement of 10–20°C above ambient has produced measurable acceleration in biological degradation rates. In a number of cases, the post-thermal biological window sustained elevated performance for years after active heating ended, as the warmed and biologically active zone continued to self-sustain degradation at elevated rates.
The pattern holds regardless of contaminant class and regardless of whether thermal enhancement was implemented as the original remedy design or as a retrofit to an underperforming passive system: warm the groundwater, and the biology responds.
The Historical Problem Was Delivery.
Knowing that heat accelerates biodegradation and being able to deliver that heat affordably and controllably to a large dissolved plume are two different problems. Traditional thermal conduction heating infrastructure was designed for high-temperature source zone treatment — aggressive thermal destruction of NAPL in a relatively tight target interval. It was not designed for sustained, low-gradient, large-footprint heating of a dissolved plume at 30–40°C. The cost and infrastructure requirements made it impractical for most ISB enhancement applications, and effectively removed it as a viable option during technology screening for new remedies.
That delivery gap is what ThermaCycle® was designed to close.
What ThermaCycle® Does
ThermaCycle® is ERG's proprietary closed-loop recirculating groundwater system. Extracted groundwater is heated to 100–180°F and reinjected at 5–50 gpm, delivering a sustained and controllable thermal boost to the target treatment interval. Amendments — electron donors, bioaugmentation cultures, pH buffers, or oxygen sources depending on the contaminant and degradation pathway — are co-delivered through the same recirculation loop via an inline dosing system, with no separate injection infrastructure required.
The platform is contaminant-agnostic. For CVOC sites, ThermaCycle® accelerates reductive dechlorination while sustaining the anaerobic conditions dechlorinating organisms require. For petroleum hydrocarbon sites, the same thermal boost enhances aerobic degradation of BTEX and lighter TPH fractions and supports sulfate-reducing and methanogenic pathways for heavier or more recalcitrant fractions. For mixed-plume sites, thermal zoning and amendment selection can be tailored to address both contaminant classes within the same operational footprint.
Critically, ThermaCycle® is designed to be scalable and cost-competitive at the plume scale — which means it is viable not only as a retrofit for underperforming sites, but as a first-choice remedy design wherever the biology is right but passive ISB timelines are not.
Designed In From the Start, or Retrofitted to What's There
For sites in the RI/FS or technology screening phase, ThermaCycle® is straightforward to evaluate. If bioremediation is the preferred approach and the contaminant distribution and hydrogeology are suitable for recirculation, the thermal component adds controlled temperature management to an otherwise conventional ISB design. The result is a remedy with greater timeline confidence, greater regulatory defensibility, and a clear performance mechanism that passive ISB cannot offer.
For a site already running ISB, the integration path is equally direct. Most sites already have a recirculation wellfield, or existing monitoring and injection points that can be adapted. The ThermaCycle® skid ties into that existing infrastructure, the amendment program feeds through the inline dosing system, and warm, amendment-loaded groundwater begins circulating through the treatment zone. The microbial community — the one that has been building for years under the existing program — responds to the temperature increase within weeks to months, not years. The same bugs. The same chemistry. Add heat.
In both scenarios, a sustained 15–20°C thermal boost delivered continuously over 18–36 months can compress a remedial timeline that passive ISB was projecting at a decade or more into something measurably shorter. In many cases, that means site closure.
The Question Isn't Whether to Change the Remedy.
Whether you are staring at a stuck ISB site or staring at a blank technology screening matrix, the biological argument for in situ treatment may already be sound. The question is whether the thermal conditions in the subsurface are letting that biology perform.
In most cases, the answer isn't a different remedy. It's a warmer one.
ThermaCycle® is ERG's proprietary low-to-mid temperature thermal recirculation platform, developed for heat-enhanced bioremediation of dissolved-phase contaminant plumes. For a technical consultation on heat-enhanced bioremediation for your site, contact Robert D'Anjou at rdanjou@1erg.com or (206) 841-3284.